Improving quality control for CAR T cell therapies
Drug Discovery World
AUGUST 10, 2022
Unlike qPCR, which requires users to generate a standard curve to estimate the concentration of DNA or RNA in a sample, ddPCR technology quantifies nucleic acids directly. Given the risks, it is important to detecta nd screen out RCVs in CAR T cell therapy batches. Cell-based assays often require considerable time to produce results.
246 
Let's personalize your content